Inclusion Criteria:

• * Patients presenting for obstetric care at Marshall University (Huntington office and Teays Valley office) between 12 and 16 weeks gestation with a systolic blood pressure of 120 or greater OR a diastolic blood pressure of 80 or greater. Eligibility for this study will be have blood pressures between 120-139 systolic and 80-89 diastolic. Randomization to control, labetalol, or nifedipine will be performed after patient consent.

Exclusion Criteria:

• * Patients already be on medication for hypertension.
• * Patients with the diagnosis of chronic hypertension
• * Patients with a BP of 140 or greater systolic OR 90 or greater diastolic (this meets criteria for chronic hypertension in pregnancy).
• * Patients actively using any illicit substance or have history of substance use disorder.
• * Patients who are actively consuming alcohol during pregnancy.
• * Patients with Type I or Type II Diabetes Mellitus.
• * Patients with end stage renal disease.
• * Patients less then 12 weeks gestation or greater than 16 weeks